AME

Business Profile & Competitive Position

AMETEK, Inc. operates in the Industrials sector, specifically the Electrical Equipment & Parts industry. It is a global manufacturer of electronic instruments and electromechanical devices, organized into two operating groups: Electronic Instruments (EIG) and Electromechanical (EMG). EIG designs and produces advanced analytical, test and measurement instruments for the process, aerospace, power and industrial markets. EMG supplies precision motion control solutions, highly engineered medical components and devices, thermal management systems, specialty metals and electrical interconnects, primarily to aerospace and defense, medical, automation and other industrial end markets.

AMETEK’s financial profile supports the view that it occupies a defensible niche in specialized, often mission-critical components and instruments. The company reports a 20.0% net margin and a 14.5% return on equity. A 20% net margin is unusually strong for a broad industrial and suggests that its product mix—heavily weighted toward differentiated instrumentation, precision components and aftermarket solutions—carries pricing power and relatively low commoditization risk. The 14.5% ROE indicates that management has deployed capital effectively, a pattern reinforced by the company’s stated emphasis on superior return on total capital. The beta of 1.00 means the stock has historically moved roughly in line with the broader market, not showing the exaggerated cyclical swings typical of more commodity-exposed industrial names.

Financial Posture

As of the snapshot, AMETEK carries a market capitalization of $54.9 billion and trades at a P/E ratio of 34.9. That valuation multiple sits at a premium to many large-cap industrial peers, reflecting the company’s above-average profitability and consistent earnings delivery rather than a deep-value posture. The 20.0% net margin reinforces the premium, because few diversified industrial conglomerates sustain profitability at that level. The 14.5% ROE, combined with the disciplined return-on-capital focus cited in the company’s 10-K, points to an organization that prioritizes accretive capital allocation over sheer scale.

The beta of 1.00 also matters for context: AMETEK’s stock has tended to track the overall market, so its valuation is less likely to be driven by idiosyncratic volatility and more by the market’s assessment of its earnings durability. The available data does not include a specific net-debt or leverage figure, but the company’s emphasis on strong cash flow generation and its ability to spend $933.2 million in cash, net of cash acquired, on 2025 acquisitions suggests a balance sheet that management views as supportive of ongoing investment.

Strategic Priorities & Outlook

AMETEK’s most recent 10-K lays out a clear operating framework. The company is executing what it calls the AMETEK Growth Model, which targets high-single-digit annual sales growth, double-digit annual EPS growth, strong free cash flow and a superior return on total capital. In 2025, the model showed measurable progress: sales reached $7,401.1 million, up 6.6% from 2024, while diluted EPS came in at $6.40, up 7.9%. The year also produced record operating income, net income, orders and backlog.

Operationally, AMETEK is focused on advancing operational excellence through lean manufacturing, global sourcing, Design for Six Sigma, Value Engineering/Value Analysis, growth kaizens, digitalization and the use of artificial intelligence. The 10-K also flags a consistent acquisition program as central to strategy: from 2021 through December 31, 2025, AMETEK completed 15 acquisitions representing approximately $1.8 billion in annualized sales. In 2025 alone, it spent $933.2 million in cash, net of cash acquired, to acquire Kern (high-precision machining and optical inspection solutions) and FARO Technologies (3D measurement and imaging solutions). Geographic expansion is another pillar, with best-cost manufacturing facilities in China, Czechia, Malaysia, Mexico and Serbia aimed at customer proximity and international growth.

International revenue is already meaningful: in 2025, 52% of EIG’s net sales and 42% of EMG’s net sales went to customers outside the United States. The workforce stood at approximately 22,500 people as of December 31, 2025.

Macro & Geopolitical Exposure

Because AMETEK sits in the Electrical Equipment & Parts industry, its exposures map closely to global industrial activity, aerospace and defense capital spending, medical device demand, process automation, power markets and broader manufacturing capital expenditure cycles. A company in this space is generally exposed to commodity input costs—copper, aluminum, specialty metals and electronic components—as well as to freight, logistics and tariffs on cross-border components and finished goods. Currency translation matters too, given the meaningful share of revenue generated outside the United States.

Additional industry-level risks include regulation of aerospace parts, medical device standards, export controls on defense-related products, and the possibility of disrupted supply chains or retaliatory trade measures in key manufacturing regions. AMETEK’s facility footprint in China, Czechia, Malaysia, Mexico and Serbia offers local-market access but also ties a portion of its cost base and supply chain to trade policy and geopolitical developments in those regions.

Recent Developments

The most recent news flow has been favorable. On August 21, 2026, Zacks published “Ametek (AME) Upgraded to Buy: Here's Why,” and the same day ran “5 High ROE Stocks to Buy as Markets Sway on Intense Volatility,” which included AMETEK as an example of an attractive ROE name. Earlier, on August 10, 2026, Zacks featured AMETEK in “Top 3D Printing Stocks to Buy for Strong Long-Term Potential,” likely connecting the company’s FARO Technologies 3D measurement and imaging capabilities to additive-manufacturing workflows, and also ran “Are You Looking for a Top Momentum Pick? Why Ametek (AME) is a Great Choice.”

These headlines are consistent with the data points discussed above: a company with consistent earnings beats, high return on equity and a recent acquisition that slots into secular manufacturing themes such as precision measurement, automation and digitalization.

Earnings Behavior & Post-Earnings Drift

AMETEK has a strong recent earnings record. Over the last eight reported quarters, it has beaten consensus estimates every time, for a beat rate of 8/8, or 100%. The average earnings surprise across those quarters is 4%. Despite the reliability of the beats, post-earnings price drift has been modest. The average 5-day price move following earnings across those quarters is 0.46%, classified as “flat.”

The last four quarters illustrate that pattern clearly:

• On August 4, 2026, AMETEK reported actual EPS of $2.09 against an estimate of $1.99, a 5.0% surprise. The stock rose 0.28% the next day and 0.89% over the following five days.
• On April 30, 2026, actual EPS was $1.97 versus $1.90 estimated, a 3.7% surprise. The next-day move was -2.13%, and the five-day drift was -0.33%.
• On February 3, 2026, AMETEK delivered $2.01 versus $1.94 estimated, a 3.6% surprise. The stock fell 0.48% the next day but drifted up 1.83% over the following five sessions.
• On October 30, 2025, actual EPS of $1.89 beat the $1.76 estimate by 7.4%. The next-day gain was 1.91%, yet the five-day drift reversed to -0.54%.

One interpretation is that the market’s real expectation already prices in the likelihood of a beat, so even solid surprises do not reliably ignite a directional move. The unofficial consensus for the next scheduled report, due October 29, 2026 before the open, currently stands at EPS of $2.10. At the current snapshot, the stock trades at $239.495, with an RSI of 41.4 and a 50-day EMA of $241.62—slightly below the short-term moving average after a recent pullback.

For a deeper view of how institutional analysts currently weigh AMETEK’s valuation, earnings consistency, acquisition strategy and macro exposures, review the full institutional verdict on the platform.